{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:20:20Z","timestamp":1792704020652,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012957","name":"Friedrich-Schiller-Universit\u00e4t Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Inflammatory rheumatic diseases (IRD) are often associated with interstitial lung disease (ILD). The aim of the present study was to establish a correlation between the findings on HRCT and the immunological bronchoalveolar lavage (BAL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included 74 patients with newly diagnosed IRD and evidence of ILD on HRCT with the following pattern: ground-glass opacities (GGO), non-specific interstitial pneumonia (NSIP) and usual interstitial pneumonia (UIP). Patients with other HRCT pattern were excluded. No patient received any immunosuppressive therapy. In addition to HRCT, immunological BAL was performed and the American Thoracic Society clinical practice guideline were used to define BAL patterns (lymphocytic cellular pattern, neutrophilic cellular pattern, eosinophilic cellular pattern and unspecified pattern).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The main HRCT patterns were NSIP (47.3%), GGO (33.8%), and UIP (18.9%). BAL patterns showed the following distribution: 41.9% lymphocytic cellular pattern, 23.0% neutrophilic cellular pattern, 18.9% eosinophilic cellular pattern, and 16.2% unspecific cellular pattern. Placing these data in the context of the HRCT findings, the lymphocytic cellular BAL pattern (48%) was most commonly BAL pattern associated with GGO pattern in HRCT, whereas neutrophilic and lymphocytic cellular BAL patterns were the dominant feature in NSIP and UIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with new-onset IRD and ILD, inflammatory pulmonary changes are predominate, reflected by GGO on HRCT and a mainly lymphocytic cell profile in the immunological BAL. In NSIP or UIP on HRCT, the percentages of lymphocytes and neutrophils were higher in BAL fluid, representing a fibrotic component in addition to the inflammation. Consequently, patients with evidence of GGO on HRCT should primarily be treated with anti-inflammatory\/immunosuppressive therapy, whereas in patients with NSIP and UIP a combination of anti-inflammatory and anti-fibrotic agents would be the appropriate treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-024-03371-0","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T05:05:07Z","timestamp":1722229507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies"],"prefix":"10.1186","volume":"26","author":[{"given":"Tobias","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Teichgr\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Oelzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Kroegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Renz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Weise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Christian","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"3371_CR1","doi-asserted-by":"publisher","first-page":"1101448","DOI":"10.3389\/fmed.2022.1101448","volume":"9","author":"T Hoffmann","year":"2022","unstructured":"Hoffmann T, Oelzner P, Teichgr\u00e4ber U, Franz M, Ga\u00dfler N, Kroegel C, Wolf G, Pfeil A. Diagnosing lung involvement in inflammatory rheumatic diseases-where do we currently stand? Front Med (Lausanne). 2022;9:1101448.","journal-title":"Front Med (Lausanne)"},{"key":"3371_CR2","doi-asserted-by":"crossref","unstructured":"Hoffmann T, Oelzner P, Busch M, Franz M, Teichgr\u00e4ber U, Kroegel C, Schulze PC, Wolf G, Pfeil A. Organ manifestation and systematic organ screening at the Onset of Inflammatory Rheumatic diseases. Diagnostics (Basel) 2021, 12(1).","DOI":"10.3390\/diagnostics12010067"},{"issue":"3","key":"3371_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12016-022-08926-0","volume":"63","author":"E De Zorzi","year":"2022","unstructured":"De Zorzi E, Spagnolo P, Cocconcelli E, Balestro E, Iaccarino L, Gatto M, Benvenuti F, Bernardinello N, Doria A, Maher TM, et al. Thoracic involvement in systemic Autoimmune Rheumatic diseases: Pathogenesis and Management. Clin Rev Allergy Immunol. 2022;63(3):472\u201389.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3371_CR4","first-page":"100948","volume":"83","author":"V Cottin","year":"2022","unstructured":"Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, W\u00e9meau-Stervinou L, Bergot E, Blanchard E, et al. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis \u2013\u20092021 update. Full-length version. Respir Med Res. 2022;83:100948.","journal-title":"Respir Med Res"},{"key":"3371_CR5","unstructured":"Kreuter M, Behr J, Bonella F, Costabel U, Gerber A, Hamer OW, Heussel CP, Jonigk D, Krause A, Koschel D et al. [Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases]. Pneumologie 2023."},{"issue":"9","key":"3371_CR6","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3371_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6(2):138\u201353.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"3371_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1055\/s-2007-991525","volume":"28","author":"U Costabel","year":"2007","unstructured":"Costabel U, Guzman J, Bonella F, Oshimo S. Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med. 2007;28(5):514\u201324.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"3371_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1055\/s-0030-1262207","volume":"31","author":"U Costabel","year":"2010","unstructured":"Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31(4):404\u20138.","journal-title":"Semin Respir Crit Care Med"},{"issue":"9","key":"3371_CR10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"3371_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1148\/radiology.189.3.8234692","volume":"189","author":"M Remy-Jardin","year":"1993","unstructured":"Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance o fground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-Ct correlation. Radiology. 1993;189:693\u20138.","journal-title":"Radiology"},{"issue":"2","key":"3371_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/thorax.58.2.143","volume":"58","author":"KR Flaherty","year":"2003","unstructured":"Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, Travis WD, Mumford JA, Murray S, Flint A, Lynch JP 3rd, Martinez FJ. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003;58(2):143\u20138.","journal-title":"Thorax"},{"issue":"6","key":"3371_CR13","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1378\/chest.14-3174","volume":"148","author":"N Omote","year":"2015","unstructured":"Omote N, Taniguchi H, Kondoh Y, Watanabe N, Sakamoto K, Kimura T, Kataoka K, Johkoh T, Fujimoto K, Fukuoka J, Otani K, Nishiyama O, Hasegawa Y. Lung-Dominant Connective tissue disease: clinical, radiologic, and histologic features. Chest. 2015;148(6):1438\u201346.","journal-title":"Chest"},{"issue":"2","key":"3371_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pulmoe.2020.01.004","volume":"28","author":"RP Oliveira","year":"2022","unstructured":"Oliveira RP, Ribeiro R, Melo L, Grima B, Oliveira S, Alves JD. Connective tissue disease-associated interstitial lung disease. Pulmonology. 2022;28(2):113\u20138.","journal-title":"Pulmonology"},{"issue":"1","key":"3371_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-022-02786-x","volume":"24","author":"T Hoffmann","year":"2022","unstructured":"Hoffmann T, Oelzner P, Franz M, Teichgr\u00e4ber U, Renz D, F\u00f6rster M, B\u00f6ttcher J, Kroegel C, Schulze PC, Wolf G, et al. Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases. Arthritis Res Ther. 2022;24(1):107.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"3371_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/01.rti.0000213572.16904.40","volume":"22","author":"RM Shah","year":"2007","unstructured":"Shah RM, Jimenez S, Wechsler R. Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis. J Thorac Imaging. 2007;22(2):120\u20134.","journal-title":"J Thorac Imaging"},{"issue":"2","key":"3371_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/resp.12674","volume":"21","author":"EA Belloli","year":"2016","unstructured":"Belloli EA, Beckford R, Hadley R, Flaherty KR. Idiopathic non-specific interstitial pneumonia. Rev Respirol. 2016;21(2):259\u201368.","journal-title":"Rev Respirol"},{"issue":"4","key":"3371_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.rmed.2009.11.008","volume":"104","author":"P Korosec","year":"2010","unstructured":"Korosec P, Rijavec M, Silar M, Kern I, Kosnik M, Osolnik K. Deficiency of pulmonary Valpha24 Vbeta11 natural killer T cells in corticosteroid-na\u00efve sarcoidosis patients. Respir Med. 2010;104(4):571\u20137.","journal-title":"Respir Med"},{"issue":"2","key":"3371_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1378\/chest.104.2.352","volume":"104","author":"RH Winterbauer","year":"1993","unstructured":"Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest. 1993;104(2):352\u201361.","journal-title":"Chest"},{"key":"3371_CR20","doi-asserted-by":"crossref","unstructured":"Orlandi M, Meliante LA, Damiani A, Tofani L, Bruni C, Guiducci S, Matucci-Cerinic M, Bellando-Randone S, Tomassetti S. The role of Bronchoalveolar Lavage in systemic sclerosis interstitial lung disease: a systematic literature review. Pharmaceuticals (Basel) 2022, 15(12).","DOI":"10.3390\/ph15121584"},{"issue":"11","key":"3371_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/art.1780271107","volume":"27","author":"RM Silver","year":"1984","unstructured":"Silver RM, Metcalf JF, Stanley JH, LeRoy EC. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 1984;27(11):1254\u201362.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3371_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3371_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12931-021-01726-8","volume":"22","author":"A Yamagata","year":"2021","unstructured":"Yamagata A, Arita M, Tachibana H, Tokioka F, Sugimoto C, Sumikawa H, Tanaka T, Yasui H, Fujisawa T, Nakamura Y, et al. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respir Res. 2021;22(1):115.","journal-title":"Respir Res"},{"key":"3371_CR24","doi-asserted-by":"crossref","unstructured":"Cassone G, Sebastiani M, Vacchi C, Erre GL, Salvarani C, Manfredi A. Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review. Drugs Context 2021, 10.","DOI":"10.7573\/dic.2020-8-8"},{"issue":"3","key":"3371_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/mr\/roac055","volume":"33","author":"Y Narita","year":"2023","unstructured":"Narita Y, Funatogawa T, Mii K, Adachi H, Tamura A, Yamakido S. Use of biologics for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: information from a Japanese hospital claims database. Mod Rheumatol. 2023;33(3):525\u201332.","journal-title":"Mod Rheumatol"},{"issue":"22","key":"3371_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071\u201382.","journal-title":"N Engl J Med"},{"issue":"2","key":"3371_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/acr2.11516","volume":"5","author":"T Hoffmann","year":"2023","unstructured":"Hoffmann T, Gassler N, Teichgr\u00e4ber U, Sandhaus T, Oelzner P, Wolf G, Pfeil A. Clinical images: severe interstitial lung disease in Sj\u00f6gren disease - what happens in the lungs? Inflammation or fibrosis? ACR Open Rheumatol. 2023;5(2):61\u20132.","journal-title":"ACR Open Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03371-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03371-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03371-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T05:15:09Z","timestamp":1722230109000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03371-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3371"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03371-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4086490\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All examinations were performed in accordance with the rules and regulations of the local Human Research and Ethics Committee of the Friedrich-Schiller-University Jena (Germany). The study is registered under the following number: \u201c2020-1845-Daten\u201d. All chest x-rays and HRCT were obtained for clinical routine and not for study purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients and\/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}